
(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
Health Rounds: Regeneron drug wipes out residual multiple myeloma cells in small trial - 2
Online business Stages for Little Retailers - 3
CDC studies show value of nationwide wastewater disease surveillance, as potential funding cut looms - 4
Vote in favor of your #1 sort of juice - 5
Minneapolis ICE shooting live updates: Protests continue over agent's killing of Renee Nicole Good; Walz puts National Guard on standby
Independence from the rat race for Recent college grads: Systems and Tips
Turkey, Egypt, Qatar discuss second phase of Gaza ceasefire deal
5 Instructive Toy Brands for Youngsters
In these U.S. groups, deaths now exceed births. What’s happening?
Novo Nordisk cuts Wegovy price as CEO pledges to go 'all in' on weight loss pill
Russia earning billions from Hormuz blockade, German trade body says
Flourishing in a Remote Workplace: Individual Techniques
Fossils unearthed in Morocco are first from little-understood period of human evolution
SpaceX's 1st 'Version 3' Super Heavy Starship booster buckles under pressure during initial tests













